ETIZOLA BETA 0.25MG TABLET 10'S

Etizola Beta 0.25mg Tablet is used to treat anxiety and related disorders. It helps relieve nervousness, tension, and sleep problems.

Etizola Beta 0.25mg Tablet works by slowing down the activity of chemical messengers in the brain, thereby producing a calming and relaxing effect.

Common side effects of Etizola Beta 0.25mg Tablet include drowsiness, dizziness, fatigue, muscle weakness, and impaired coordination.

Etizola Beta 0.25mg Tablet has the potential to be habit-forming, so it should only be taken for the duration prescribed by the doctor.

Drinking alcohol with Etizola Beta 0.25mg Tablet can increase the side effects like drowsiness and dizziness, so it should be avoided.

If you miss a dose of Etizola Beta 0.25mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Etizola Beta 0.25mg Tablet is not safe for pregnant women as it can harm the fetus. Therefore, it should be taken only on the advice of a doctor.

Etizola Beta 0.25mg Tablet is not safe for breastfeeding women as it can pass into breast milk and harm the baby. Therefore, it should be taken only on the advice of a doctor.

Store Etizola Beta 0.25mg Tablet at room temperature, away from direct sunlight and heat. Keep it out of reach of children and pets.

Etizola Beta 0.25mg Tablet can interact with certain other medications, such as antidepressants, antihistamines, and opioid pain relievers. Therefore, it is important to tell your doctor about all the medications you are taking.

Symptoms of an Etizola Beta 0.25mg Tablet overdose include drowsiness, confusion, impaired coordination, slow heart rate, and difficulty breathing.

While taking Etizola Beta 0.25mg Tablet, avoid drinking alcohol, operating machinery, or doing activities that require mental alertness.

Etizola Beta 0.25mg Tablet should not be stopped suddenly, as it can cause withdrawal symptoms. It is important to talk to your doctor before stopping the medication.

It takes about 30 minutes to 1 hour for Etizola Beta 0.25mg Tablet to start working.

Weight gain is not a common side effect of Etizola Beta 0.25mg Tablet, but some people may experience an increase in appetite, which can lead to weight gain.

Etizola Beta 0.25 is a prescription combination medicine containing etizolam and propranolol. It is typically used for short-term management of anxiety disorders, performance anxiety, and related physical symptoms such as palpitations, tremors, and sweating. The etizolam component helps reduce psychological anxiety and tension, while propranolol helps control the physical manifestations of anxiety by blocking the effects of adrenaline on the heart and circulation. It should only be used under medical supervision after a proper clinical assessment.

Etizola Beta 0.25 works through two complementary mechanisms. Etizolam enhances the effect of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the brain, leading to reduced neuronal excitability and producing anxiolytic, sedative, and muscle-relaxant effects. Propranolol is a non-selective beta-adrenergic blocker that reduces heart rate, blood pressure, and tremors by blocking beta receptors in the heart and peripheral circulation. Together, they help reduce both the mental and physical symptoms of anxiety. Because of these central nervous system and cardiovascular effects, careful dosing and monitoring are required.

Etizola Beta 0.25 contains etizolam, which is pharmacologically related to benzodiazepines and has the potential to cause dependence, especially with prolonged use, high doses, or in individuals with a history of substance use disorder. Patients may develop tolerance, requiring higher doses to achieve the same effect, and may experience withdrawal symptoms if the medicine is stopped abruptly. For this reason, it is usually prescribed for the shortest duration necessary, and any discontinuation should be gradual and supervised by a doctor. Propranolol itself is not considered addictive, but sudden withdrawal after long-term use can cause rebound symptoms such as increased heart rate or blood pressure.

Driving or operating machinery while taking Etizola Beta 0.25 is generally not recommended, especially when starting treatment, after dose changes, or if you experience drowsiness, dizziness, blurred vision, or slowed reaction time. Etizolam can impair alertness, coordination, and judgment, while propranolol can cause fatigue or light-headedness in some individuals. These effects may increase the risk of accidents. You should only drive or perform hazardous tasks if your doctor agrees and you are confident that the medicine does not affect your ability to do so safely.

Alcohol should be avoided while taking Etizola Beta 0.25. Alcohol is a central nervous system depressant and can significantly enhance the sedative and respiratory-depressant effects of etizolam, leading to excessive drowsiness, impaired coordination, confusion, and, in severe cases, breathing difficulties. Alcohol can also interact with propranolol, potentially worsening low blood pressure or dizziness. Combining this medicine with alcohol increases the risk of accidents and serious adverse events, so concurrent use is strongly discouraged.

Common side effects of Etizola Beta 0.25 may include drowsiness, dizziness, fatigue, slowed reaction time, impaired concentration, headache, dry mouth, nausea, stomach discomfort, and sleep disturbances. Some patients may experience reduced blood pressure, slower heart rate, cold hands or feet, or mild shortness of breath due to propranolol. Mood changes, irritability, or worsening of underlying depression can occur in susceptible individuals. Most side effects are dose-related and may lessen as the body adjusts, but any persistent, severe, or unusual symptoms should be promptly discussed with your doctor.

Etizola Beta 0.25 is not suitable for everyone. It is generally contraindicated in patients with known hypersensitivity to etizolam, propranolol, or any excipients in the formulation; significant heart block, severe bradycardia, or uncontrolled heart failure; severe hypotension; a history of severe respiratory depression; and certain severe psychiatric conditions where sedative agents are inappropriate. It should be used with great caution, if at all, in patients with chronic obstructive pulmonary disease or asthma, severe liver or kidney impairment, depression or a history of suicidal behavior, diabetes, peripheral vascular disease, or a history of substance use disorder. A full medical history and medication review are essential before starting therapy.

Use of Etizola Beta 0.25 during pregnancy or breastfeeding is generally not recommended unless the potential benefit clearly outweighs the potential risks, and only under specialist supervision. Etizolam, like benzodiazepine-related drugs, may be associated with risks such as neonatal respiratory depression, floppy infant syndrome, or withdrawal symptoms if used in late pregnancy or at high doses. Propranolol can cross the placenta and may affect fetal heart rate and growth. Both components can pass into breast milk and may cause sedation, poor feeding, or bradycardia in the nursing infant. Pregnant or breastfeeding women should discuss alternative treatment options with their doctor.

If you miss a scheduled dose of Etizola Beta 0.25, take it as soon as you remember, unless it is almost time for your next planned dose. If the next dose is near, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for a missed one, as this may increase the risk of excessive sedation, low blood pressure, or slow heart rate. If you frequently forget doses, speak with your doctor; they may adjust your regimen or suggest strategies to improve adherence. Never change the dosing schedule on your own without medical advice.

You should not stop taking Etizola Beta 0.25 abruptly without consulting your doctor, especially if you have been using it regularly for more than a short period. Sudden discontinuation of etizolam can lead to withdrawal symptoms such as rebound anxiety, restlessness, insomnia, irritability, tremors, or, rarely, seizures. Abrupt cessation of propranolol after prolonged use may cause rebound tachycardia, increased blood pressure, or worsening of underlying heart conditions. Your doctor will usually recommend a gradual tapering schedule to minimize withdrawal or rebound effects and will monitor you during the dose reduction.

Etizola Beta 0.25 can interact with several other medicines. Etizolam may have additive sedative effects when combined with other central nervous system depressants such as benzodiazepines, opioids, certain antihistamines, antipsychotics, or alcohol. Some antidepressants, antifungals, and antibiotics can alter etizolam metabolism, potentially increasing its levels and side effects. Propranolol can interact with other blood pressure medicines, antiarrhythmics, certain antidepressants, antidiabetic agents, and drugs that affect heart rate or cardiac conduction. Because of these potential interactions, you should inform your doctor about all prescription medicines, over-the-counter products, and herbal supplements you are taking before starting Etizola Beta 0.25.